Hims stock falls below $15 in next 30 days

Hims' stock price will decline to below $15 within the next 30 days due to weaker-than-expected sales and intensified competition in the weight loss drug market. The company's failure to meet revenue targets will trigger investor concern.

Implied probability (Yes)

75%